The Effects of Probiotic Supplementation on Level of Disability, Depressive Symptoms, and Cognitive Outcomes in Relapsing-Remitting Multiple Sclerosis Patients: A Randomized Double-Blind Placebo-Controlled Trial
Background: Multiple sclerosis (MS) is a chronic autoimmune disease characterized by inflammation and demyelination of the central nervous system. Probiotics, through the gut-brain axis, are suggested to enhance clinical outcomes in patients with MS. This study scrutinizes the effects of probiotic s...
Saved in:
Main Authors: | Amirreza Naseri, Sarvin Sanaie, Sama Rahnemayan, Reza Mosaddeghi-Heris, Malihe Talebi, Mahnaz Talebi |
---|---|
Format: | Article |
Language: | English |
Published: |
Tabriz University of Medical Sciences
2025-07-01
|
Series: | Pharmaceutical Sciences |
Subjects: | |
Online Access: | https://ps.tbzmed.ac.ir/PDF/ps-31-322.pdf |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Comorbidity in in patients with relapsing-remitting multiple sclerosis
by: O.V. Somilo, et al.
Published: (2024-10-01) -
Adherence to therapeutic recommendation in relapsing-remitting multiple sclerosis patients
by: Justyna Chojdak-Łukasiewicz, et al.
Published: (2025-06-01) -
Effectiveness of Copaxone in patients with relapsing-remitting multiple sclerosis
by: V. M. Alifirova, et al.
Published: (2010-08-01) -
The condition of the cardiovascular system in patients with relapsing-remitting multiple sclerosis
by: O. A. Traktirskaya, et al.
Published: (2019-03-01) -
Predictive Significance of Interleukins 17A and 33 in Risk of Relapsing–Remitting Multiple Sclerosis
by: Milad Abdul Salam Al-Naseri, et al.
Published: (2022-12-01)